Salus
Salus is a Slovenian publicly-traded pharmaceutical wholesale distributor serving healthcare providers and pharmacies across Central and Eastern Europe, including Slovenia, Croatia, Poland, Hungary, and the Baltic states, with established multi-jurisdictional regulatory expertise.
- Company typePublic
- Founded1969
- HeadquartersLjubljana, Slovenia
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Salus does
Salus is a Slovenian pharmaceutical wholesale and distribution company founded in 1969 and publicly traded on the Ljubljana Stock Exchange under the symbol SALR (lje:SALR). The company operates a regional distribution network spanning seven Central and Eastern European markets — Slovenia, Croatia, Poland, Hungary, Estonia, Latvia, and Lithuania — serving as an intermediary between global pharmaceutical manufacturers and downstream healthcare providers, pharmacies, and hospitals. Salus employs between 501 and 1,000 people and positions itself as the regional partner of choice for manufacturers seeking compliant, multi-jurisdictional market access in CEE.
The company's go-to-market is built on channel partnerships with global pharmaceutical manufacturers. Its most prominent disclosed partnership is the July 2026 distribution agreement with Eisai EMEA for lecanemab, an Alzheimer's disease treatment, which Salus distributes across all seven of its CEE markets in accordance with local regulatory requirements and marketing authorisations. Salus generates revenue on a transaction-fee basis as a wholesale distributor, providing manufacturers local market access, regulatory compliance infrastructure, and supply chain efficiency without requiring the manufacturers to establish their own country-level operations. Its primary customer segment is healthcare providers and pharmacies, with the value proposition centred on multi-jurisdictional regulatory expertise, established supply chain networks, and CEE market knowledge.
No proprietary software products, digital platforms, AI/ML capabilities, or technology stack components are disclosed in the available source material. Pricing details and contractual structures are also not publicly disclosed. The company's competitive positioning rests on its long operating history (founded 1969), public-market capital base, established multi-country regulatory authorisations, and physical distribution infrastructure across CEE. Information on management team, M&A activity, capital raises, and detailed financial reporting (the disclosed revenue figures carry apparent unit anomalies) is not available in the supplied data.
Salus firmographics
Firmographics- Name
- Salus
- Legal name
- Salus
- Website
- https://salus.si
- Company type
- Public
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Salus is a Slovenian publicly-traded pharmaceutical wholesale distributor serving healthcare providers and pharmacies across Central and Eastern Europe, including Slovenia, Croatia, Poland, Hungary, and the Baltic states, with established multi-jurisdictional regulatory expertise.
- Ownership category
- akta.pro rank
Salus industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)
Keywords
Where Salus is headquartered
LocationHeadquarters
- HQ city
- Ljubljana
- HQ country
- Slovenia
- HQ region
- Europe
Markets served
Salus business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Supply Chain, Personnel, Infrastructure
Revenue model
- Pharmaceutical Distribution: Salus generates revenue by distributing pharmaceutical products on behalf of manufacturers. As a distribution partner for Eisai EMEA, Salus provides distribution services for lecanemab across multiple Central and Eastern European markets in accordance with applicable regulatory requirements and local marketing authorisation.
Go-to-market motion1 record
Distribution channels1 record
Salus product offering
Product offeringCore offering
Salus is a pharmaceutical wholesale and distribution company that distributes branded medications on behalf of manufacturers across Central and Eastern European markets, including Slovenia, Croatia, Poland, Hungary, and the Baltic states. The company serves as a regional distribution partner for global pharmaceutical manufacturers, providing regulatory-compliant market access and supply chain services, including distribution of specialty medications such as lecanemab under a distribution agreement with Eisai EMEA.
Product overview
Salus is a Slovenian pharmaceutical distributor that provides distribution services for medications across Central and Eastern European markets, including Slovenia, Croatia, Poland, Hungary, and the Baltic states. The company offers pharmaceutical distribution and supply chain services in accordance with applicable regulatory requirements and local marketing authorisations. No specific named software products, platforms, or modules are described in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Distribution Services
- Lecanemab Distribution (Alzheimer's disease treatment)
Companies that use Salus
Customer profileSegments1 record
Ideal customer profiles2 records
Salus technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Salus partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Eisai EMEAcoreSalus signed a distribution agreement with Eisai EMEA for the supply of lecanemab, a medication used for treating Alzheimer's disease. Salus provides distribution services across Slovenia, Croatia, Poland, Hungary, and the Baltic states in accordance with applicable regulatory requirements and local marketing authorisation. This partnership enables Eisai to expand access to lecanemab across Central and Eastern European markets through a local distribution partner.
Scale indicators2 records
Recent moves3 records
Expansion highlights4 records
Salus competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Cardinal Health is a major U.S.-headquartered pharmaceutical distributor with international operations. Comparable to Salus in core pharma distribution business model, at substantially larger scale and geographic breadth.
- Cencora (AmerisourceBergen): Cencora is one of the world's largest pharmaceutical distributors with global operations. Comparable business model to Salus, though at vastly greater scale and with more diversified service offerings including specialty distribution.
- McKesson Europe: McKesson's European arm operates pharmaceutical distribution networks in multiple countries. Comparable business model and customer base to Salus, with substantially greater scale and capital resources.
- Walgreens Boots Alliance (Alliance Healthcare): Alliance Healthcare is the pharmaceutical wholesale division of WBA, operating across Europe including CEE. Comparable to Salus in distribution model and target customers, but materially larger and more diversified.
- Phoenix Group: Phoenix Group is Europe's largest pharmaceutical wholesale group with broad pan-European coverage including CEE. Comparable to Salus as a pharmaceutical wholesaler serving multiple markets, though operating at much greater scale.
Direct peers
- PHOENIX Group (specific subsidiary: Helexis/PharmaCEE): Phoenix's CEE-focused subsidiaries operate pharmaceutical distribution across Poland, Hungary, and the Baltic states — overlapping directly with Salus's stated geographic footprint and product categories.
Regional players
- Medochemie: Medochemie is a Cyprus-based pharma manufacturer with distribution across CEE and emerging markets. Comparable to Salus in regional pharmaceutical distribution reach and target customer segments.
- KRKA: KRKA is a Slovenia-based generic pharmaceutical manufacturer with significant CEE distribution. A direct local peer sharing the same domestic market as Salus, though more manufacturing-oriented.
- Sopharma Trading: Sopharma Trading is a Bulgarian pharmaceutical wholesaler/distributor serving CEE. Comparable to Salus as a regional pharma distributor with similar product portfolio and customer base, focused on a different primary geography.
Emerging players
- Zentiva: Zentiva is a CEE-headquartered pharmaceutical company with distribution operations across the region. Comparable to Salus in CEE market focus and pharmaceutical supply-chain exposure, though more manufacturer-led.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Salus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Salus leadership team
Management profileNumber of profiles
Salus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Salus M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Salus
What does Salus do?
Salus is a pharmaceutical wholesale and distribution company that distributes branded medications on behalf of manufacturers across Central and Eastern European markets, including Slovenia, Croatia, Poland, Hungary, and the Baltic states. The company serves as a regional distribution partner for global pharmaceutical manufacturers, providing regulatory-compliant market access and supply chain services, including distribution of specialty medications such as lecanemab under a distribution agreement with Eisai EMEA.
Is Salus a public or private company?
Salus is a public company. It is classified as public and is currently operating.
When was Salus founded?
Salus was founded in 1969. It employs 501 to 1,000 people.
Where is Salus based?
Salus is headquartered in Ljubljana, Slovenia, in the Europe region.
How does Salus make money?
One revenue line is on record: pharmaceutical Distribution.
Who are Salus's main competitors?
Broad incumbents on record are Cardinal Health, Cencora (AmerisourceBergen), McKesson Europe, Walgreens Boots Alliance (Alliance Healthcare) and Phoenix Group. PHOENIX Group (specific subsidiary: Helexis/PharmaCEE) is listed as a direct peer. Regional players are Medochemie, KRKA and Sopharma Trading. Zentiva is listed as an emerging player.
Does Salus have an API?
No public API is recorded for Salus.
What industry is Salus in?
Salus's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAG, Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience). Its NAICS code is 424210 and its SIC code is 5122.